America’s S&P 500 index plunged by a third when the coronavirus crisis struck. But it has since rallied and is back to where it was at the beginning of the year. The remarkable rebound suggests that this may be a good time to consider some short-selling ideas. One company that looks a prime target for short-selling is health insurance broker eHealth (Nasdaq: EHTH). The group is in a sector beset by continual regulatory scrutiny, but has nonetheless been on a tremendous tear over the past two years, rising from under $25 a share in June 2018 to around $120 today.
The reason for this surge is that between 2017 and 2019 sales more than doubled, while they are projected to increase by another 50% between 2019 and 2021. The company, previously loss-making, is now making a large profit. It says this is due to the rising popularity of its platform, which allows Americans to compare health-insurance plans online.
Just as online brokers have revolutionised real estate, eHealth aims to do the same for American healthcare, helping consumers reduce the cost and complexity of what is generally deemed one of the most complicated and expensive health systems in the world.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
How secure are sales?
However, the firm has attracted increasing attention from activist short-sellers, who argue that most of eHealth’s increase in revenue comes from changes to accounting rules a few years ago. The company uses the “mark to model” accounting technique, which lets it book expected sales and profits over the lifetime of a client.
Crucially, these expected sales and profits are based on eHealth’s own assumptions about how long people will remain customers, so if they cancel their plans, or stay with eHealth for a shorter period than expected, then the anticipated commissions could fail to materialise. They also argue that eHealth’s assumptions may be overly optimistic in that they depend on customers who have traditionally changed their plans regularly sticking with their provider.
It is always possible that eHealth’s projections could be proved correct and the short-sellers proved wrong. Still, there are several reasons why I think that the company is overvalued. Firstly, the mark to model technique has a terrible reputation, so I would be sceptical about any company that used it. The fact that the company is currently burning through large amounts of cash isn’t a good sign either. What’s more, I think that the current valuation of 24.6 times 2021 earnings is very high for a company in an industry under increasing political scrutiny.
I therefore suggest that you short eHealth at the current price of $118. Given how volatile the stock can be, stake £20 per $1 (a lower level than I’d normally recommend, with a wider stop-loss), covering your position if it rises above $168. This gives you a total downside of £1,000.
-
Which investment trusts could benefit from lower interest rates?As vehicles for long-term investments, many investment trusts were hit when interest rates rose in 2022. With interest rates expected to fall by the end of the year, could now be the time to invest in one of these unloved sectors?
-
How to protect your personal and financial data from cyber attacksM&S and the Co-op are the latest retailers to suffer from cyber hacks but consumers also need to be vigilant
-
The Burberry share price looks like a good betTips The Burberry share price could be on the verge of a major upswing as the firm’s profits return to growth.
-
Why you should short this satellite broadband companyTips With an ill-considered business plan, satellite broadband company AST SpaceMobile is doomed to failure, says Matthew Partridge. Here's how to short the stock.
-
It’s time to sell this stockTips Digital Realty’s data-storage business model is moribund, consumed by the rise of cloud computing. Here's how you could short the shares, says Matthew Partridge.
-
Netflix has plenty of life in it yet – here's how to trade the sharesTips Netflix still has plenty of scope for growth, says Matthew Partridge, and the shares are reasonably priced. Here's how to play the Netflix share price.
-
Trading: Dunelm will keep growing, here's how to play itTips Furniture retailer Dunelm surged during the pandemic, but its shares have since fallen back. But it is well placed to take more market share from rivals, says Matthew Partridge. Here, he explains how to play the Dunelm share price.
-
Ashtead – a building equipment rental firm on solid foundationsTips The prospects for Ashtead, the building-equipment rental firm, are auspicious. Matthew Partridge explains the best way to play the share price.
-
A recruitment firm to bet on as the world gets back to workTips Recruitment consultant Hays has been volatile, but results are strong and trends encouraging. Matthew Partridge explains the best way to play the share price.
-
What is next for interdealer broker TP Icap?Analysis TP Icap has struggled in a declining market, but there’s still a role for its services. Bruce Packard explains what that is.
